宜宾眼皮变成三眼皮宜宾微整形多少钱,宜宾鼻子做假体多久恢复,宜宾双眼皮手术后的护理,宜宾丰胸美容,宜宾哪双眼皮做的好,宜宾隆鼻整形手术,宜宾哪个地方做双眼皮好

XICHANG, Sichuan, July 27 (Xinhua)-- China successfully launched an orbiter into space at 5:44 a.m. Beijing Time Wednesday, as a part of its indigenous satellite navigation and positioning network known as Beidou, or Compass system, sources with the launch center said.The orbiter,launched from the Xichang Satellite Launch Center in southwestern Sichuan Province, was boosted by a Long March-3A carrier rocket into a geostationary orbit.China started to build up its own satellite navigation system to break its dependence on the U.S. Global Positioning System (GPS) in 2000.A Long March-3A carrier rocket lifts off at the Xichang Satellite Launch Center in southwest China's Sichuan Province, July 27, 2011. China successfully launched into space a ninth orbiter for its independent satellite navigation and positioning network known as Beidou, or Compass System here early WednesdayBetween October 2000 and May 2003, the country set up a regional satellite navigation system after launching three Beidou geostationary satellites.The system was known as Beidou-1 and is said to have played an important role in the rescue efforts following the devastating earthquake in May 2008 in Wenchuan as it provided the only channel connecting the quake-hit area and the outside.The Beidou-1 system can not meet growing demand, so a better functional Beidou-2 regional and global navigation system will be set up, Qi Faren, former chief designer for Shenzhou spaceships said in an interview with Xinhua early this year.From April 2007 to April this year, China launched another eight orbiters to form its Beidou-2 system, which will eventually consist of 35 satellites.The network will provide satellite navigation, time and short message services for Asia-Pacific regions by 2012 and global services by 2020.

WASHINGTON, Sept. 13 (Xinhua) -- The U.S. Department of Agriculture (USDA) announced Tuesday it will begin testing next year for six more kinds of E.coli bacteria in raw ground beef and tenderized steaks in order to protect the safety of the American food supply.The U.S. currently tests for one strain of E.coli O157:H7 in beef. According to the USDA, from March 5 next year, if the E. coli serogroups O26, O103, O45, O111, O121 and O145 are found in raw ground beef or its precursors, those products will be prohibited from entering commerce.Like E.coli O157:H7, these serogroups can cause severe illness and even death, and young children and the elderly are at highest risk."The Obama Administration is committed to protecting our food supply and preventing illnesses before they happen," said Agriculture Secretary Tom Vilsack in a statement. "Today's announcement does exactly that by targeting and eliminating contaminated products from the market.""Too often, we are caught reacting to a problem instead of preventing it. This new policy will help stop problems before they start," he said.About one in six Americans becomes sick from a food borne illnesses each year, an epidemic that kills about 3,000 annually and hospitalizes 128,000, according to the U.S. Centers for Disease Control and Prevention.

STOCKHOLM, Aug. 30 (Xinhua) -- Meat diet, a dietary habit popular in some developed countries, can produce more greenhouse gas and thus is likely to actually cause more impact on climate, said a Swedish study published Tuesday.According to Swedish Radio's Ekot news program, the meat diet, also known as Low Carb High Fat (LCHF) diet, doubled the greenhouse gas emission compared with the balanced diet recommended by the Swedish Food Administration.Many Swedish people have abandoned the diet habit of eating root vegetables and fruits, and switched to LCHF diets. The LCHF diet has more meat, fat and unusual greenhouse gas emission. But these root vegetables, such as potatoes and carrots, and other naturally grown vegetables can be planted with less greenhouse gas emission.The report also revealed that many of the LCHF diet advices are actually given by the researchers sponsored by meat industry.

LOS ANGELES, June 24 (Xinhua) -- Near-Earth asteroid 2011 MD will whip past Earth on June 27, but will not pose any threat, NASA's Jet Propulsion Laboratory (JPL) said on Friday.The asteroid will pass only 12,000 kilometers (7,500 miles) above the Earth's surface at about 9:30 EDT, according to JPL in Pasadena, Los Angeles.This small asteroid, only 5-20 meters in diameter, is in a very Earth-like orbit about the Sun, but an orbital analysis indicates there is no chance it will actually strike Earth on Monday, JPL said.If a rocky asteroid the size of 2011 MD were to enter Earth's atmosphere, it would be expected to burn up high in the atmosphere and cause no damage to Earth's surface, said JPL.The accompanying diagram gives a view of the asteroid's trajectory from the general direction of the Sun. This view indicates that 2011 MD will reach its closest Earth approach point in extreme southern latitudes (in fact over the southern Atlantic Ocean), according to JPL. The incoming trajectory leg passes several thousand kilometers outside the geosynchronous ring of satellites and the outgoing leg passes well inside the ring, JPL said.For a brief time, it may be bright enough to be seen even with a modest-sized telescope.One would expect an object of this size to come this close to Earth about every six years on average.The asteroid was discovered by the LINEAR near-Earth object discovery team observing from Socorro, New Mexico.

LOS ANGELES, June 5 (Xinhua) -- A latest study has found no evidence that screening for ovarian cancer may reduce the risk of dying from the disease, it was reported on Sunday.Screening, however, does increase the likelihood of unnecessary invasive procedures, according to researchers at the University of Utah.The researchers presented their findings at an on-going meeting of the American Society of Clinical Oncology in Chicago, The Los Angeles Times said.Researchers studied 78,216 women, ages 55 to 74, who participated in the National Cancer Institute's Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Half of the women received the usual care from their OB-gyns, and half received a CA 125 screening every year for six years and an ultrasound every year for four years. They were then followed for a maximum of 12 years.The researchers observed 212 ovarian cancers in the screened group and 176 in the normal care group. There were 118 ovarian cancer deaths in the screened group and 100 in the normal care group. The differences were not statistically significant. Overall, there were 2,924 deaths from all causes in the screened group and 2,914 in the normal care group.But the researchers also observed that 3,285 women had false- positive diagnoses from the screening. Among those, 1,080 underwent surgery that included an oophorectomy (surgical removal of one or both ovaries). Fifteen percent of those who had surgery developed major complications as a result. Overall, 1,771 women in the screened group (7.7 percent) had an oophorectomy, compared with 1,304 in the normal care group (5.8 percent)."We conclude that annual screening for ovarian cancer ... does not reduce disease-specific mortality in women at average risk for ovarian cancer but does increase invasive medical procedures and associated harms," the researchers said in the study.New data presented at the meeting also showed that the widely used cancer drug Avastin can improve treatment of ovarian cancer, The Times said.About 21,880 American women are diagnosed with ovarian cancer each year and about 13,850 die from it, according to the American Cancer Society. Because it produces few symptoms, the disease is typically not diagnosed until it has become advanced and spread throughout the body. As a result, five-year survival is only about 30 percent, and the disease is one of the five most deadly cancers among women. Being able to detect the cancer at an earlier stage when it might be more curable could thus, theoretically, improve the survival rate.The tests most commonly used to detect ovarian cancer include a transvaginal ultrasound to look for tumor masses and a blood test that screens for increased levels of a tumor marker called CA 125.